Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe LANCET REG HEALTH-EU
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis Front Immunol
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults Front Immunol
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma CL LYMPH MYELOM LEUK
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19 THROMB HAEMOSTASIS
Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study LANCET REG HEALTH-EU
Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates Mater Today Bio